REporting recommendations for tumour MARKer prognostic studies (REMARK)

British Journal of Cancer

Volumn 93, Issue 4, 2005, Pages 385-386

  Harris, A L ^a,b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RESEARCH; DISEASE MARKER; DNA EXTRACTION; EDITORIAL; GENETIC ANALYSIS; HUMAN; MEDICAL ETHICS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDATION PROCESS; CHEMISTRY; EVIDENCE BASED MEDICINE; GENE EXPRESSION PROFILING; NOTE; PROGNOSIS; REPRODUCIBILITY; STANDARD;

TUMOR MARKER;

CHEMISTRY, ANALYTICAL; EVIDENCE-BASED MEDICINE; GENE EXPRESSION PROFILING; HUMANS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 24944471459     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602730     Document Type: Editorial

References (3)

1. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2005) REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer 93: 387-391
2. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351: 2817-2826
3. Rimm DL (2005) Tissue microarrays without cores. Nat Methods 2: 492-493